Antiprogestins as a model for progesterone withdrawal

Steroids

Volumn 68, Issue 10-13, 2003, Pages 1061-1068

  Critchley, Hilary O D ^a   Kelly, Rodney W ^a   Brenner, Robert M ^b   Baird, David T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antiprogestins; Endometrium; Progesterone; Steroid receptors

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANTIGESTAGEN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MIFEPRISTONE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGESTERONE; SEX HORMONE;

CONFERENCE PAPER; DOWN REGULATION; FIRST TRIMESTER PREGNANCY; HORMONE ACTION; HUMAN; IMPLANTATION; INDUCED ABORTION; LUTEAL PHASE; MENSTRUATION; NONHUMAN; PREGNANCY DISORDER; UPREGULATION; UTERUS BLEEDING;

EID: 0346996799     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2003.07.001     Document Type: Conference Paper

References (70)

1. Critchley H.O.D., Kelly R.W., Brenner R.M., Baird D.T. The endocrinology of menstruation - a role for the immune system. Clin. Endocrinol. 55:2001;701-710.
2. Garcia E., Bouchard P., DeBrux J., Berdah J., Frydman R., Schaison G.et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J. Clin. Endocrinol. Metab. 67:1988;80-87.
3. Lessey B.A., Killam A.P., Metzger D.A., Haney A.F., Greene G.L., McCarty K.S. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J. Clin. Endocrinol. Metab. 67:1988;334-340.
4. Snijders M.P., de Goeij A.F.P.M., Debets-Te Baerts M.J.C., Rousch M.J., Koudstaal J., Bosman F.T. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J. Reprod. Fertil. 94:1992;363-371.
5. Slayden O.D., Nayak N.R., Chwalisz K., Cameron S.T., Critchley H.O.D., Baird D.T.et al. Progesterone antagonists increase the androgen receptor expression in the rhesus macaque and human endometrium. J. Clin. Endocrinol. Metab. 86:2001;2668-2679.
6. Critchley H.O.D., Brenner R.M., Drudy T.A., Williams K., Nayak N.R., Slayden O.D.et al. Estrogen receptor beta, but not estrogen receptor alpha, is present in vascular endothelium of the human and nonhuman primate endometrium. J. Clin. Endocrinol. Metab. 86:2001;1370-1378.
7. Kumar S., Zhu L.-J., Polihronis M., Cameron S.T., Baird D.T., Schatz F. et al. Progesterone induces calcitonin gene expression in human endometrium within the putative window of implantation. J. Clin. Endocrinol. Metab. 83:1998;4444-4450.
8. Chard T., Olajide F. Endometrial protein PP14: a new test of endometrial function. Reprod. Med. Rev. 3:1994;43-52.
9. Casey M.L., Hemsell D.L., MacDonald P.C., Johnston J.M. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in human endometrium. Prostaglandins. 19:1980;115-122.
10. Cameron S.T., Critchley H.O.D., Buckley C.H., Chard T., Baird D.T. The effects of post ovulatory administration of onapristone on the development of a secretory endometrium. Hum. Reprod. 11:1996;40-49.
11. Greenland K.J., Jantke I., Jennatschke S., Bracken K.E., Vinson C., Gellerson B. The human NAD+ dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone. Endocrinology. 141:2000;581-597.
12. Maentausta O., Svalander P., Gemzell-Danielsson K., Bygdeman M., Vihko R. The effects of an antiprogestin, mifepristone, and an anti-estrogen, tamoxifen, on endometrial 17β hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. J. Clin. Endocrinol. Metab. 77:1993;913-918.
13. Critchley H.O.D., Wang H., Jones R.L., Kelly R.W., Drudy T.A., Gebbie A.E.et al. Morphological and functional features of endometrial decidualisation following long term intrauterine levonorgestrel delivery. Hum. Reprod. 13:1998;1218-1224.
14. Tang B., Guller S., Gurpide E. Mechanism of human endometrial stromal cell decidualization. Ann. N.Y. Acad. Sci. 734:1994;19-25.
15. Brosens J.J., Takeda S., Acevedo C.H., Lewis M.P., Kirby P.L., Symes E.K.et al. Human endometrial fibroblasts immortalized by simian virus 40 large T antigen differentiate in response to a decidualization stimulus. Endocrinology. 137:1996;2225-2231.
16. Paria B.C., Ma W.-G., Tan J., Raja S., Das S.J., Dey S.K.et al. Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. PNAS. 98:2001;1047-1052.
17. Lim H., Gupta R.A., Ma W.G., Paria B.C., Moller D.E., Morrow J.D.et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPAR delta. Genes Dev. 13(12):1999;1561-1574.
18. Benson G.V., Lim H., Paria B.C., Satokata I., Dey S.K., Maas R.L. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development (Cambridge, UK). 122(9):1996;2687-2696.
19. Gendron R.L., Paradis H., Hsieh-Li H.M., Lee D.W., Potter S.S., Markoff E. Abnormal uterine stromal and glandular function associated with maternal reproductive defects in Hoxa-11 null mice. Biol. Reprod. 56:1997;1097-1105.
20. Taylor H.S., Igarashi P., Olive D.L., Arici A. Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium. J. Clin. Endocrinol. Metab. 84(3):1999;1129-1135.
21. Osteen KG. The endocrinology of uterine decidualisation. In: Bazer FW, editor. Endocrinology of pregnancy. New Jersey: Human Press Inc.; 1999. p. 541-53.
22. Jabbour H.N., Critchley H.O.D. Potential roles of decidual prolactin in early pregnancy. Reproduction. 121:2001;197-205.
23. Maslar I.A., Ansbacher R. Effects of progesterone on decidual prolactin production by organ cultures of human endometrium. Endocrinology. 118:1986;2102-2108.
24. Wang J.D., Zhu J.B., Shi W.L., Zhu P.D. Immunocytochemical colocalisation of progesterone receptor and prolactin in individual stromal cells of human decidua. J. Clin. Endocrinol. Metab. 79:1994;293-297.
25. Jabbour H.N., Critchley H.O., Boddy S.C. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT-1), and (STAT 5) proteins are phosphorylated after stimulation with prolactin. J. Clin. Endocrinol. Metab. 83:1998;2545-2553.
26. Jones R.L., Critchley H.O.D., Brooks J., Jabbour H.N., McNeilly A.S. Localisation and temporal pattern of expression of prolactin receptor in human endometrium. J. Clin. Endocrinol. Metab. 83:1998;258-262.
27. Gubbay O., Critchley H.O.D., Bowen J.M., King A., Jabbour H.N. Prolactin induces ERK phosphorylation in epithelial and CD56+ natural killer cells of the human endometrium. J. Clin. Endocrinol. Metab. 87:2002;2329-2335.
28. Ormandy C.J., Camus A., Barra J., Damotte D., Lucas B., Buteau H.et al. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11:1997;167-178.
29. Lydon J.P., Demayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A. Jr.et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9:1995;2266-2278.
30. Clarke C.L., Sutherland R.L. Progestin regulation of cellular proliferation. Endocr. Rev. 11:1990;266-301.
31. Conneely O.M., Lydon J.P. Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids. 65:2000;571-657.
32. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 289:2000;1751-1754.
33. Csapo A.I., Resch B.A. Prevention of implantation by antiprogesterone. J. Steroid Biochem. 11:1979;963-969.
34. Csapo A.I., Pulkkinen M. Indispensibility of the human corpus luteum in the maintenance of early pregnancy. Lutectomy evidence. Obstet. Gynecol. Surv. 33:1978;69-81.
35. Jones R.L., Kelly R.W., Critchley H.O.D. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum. Reprod. 12:1997;1300-1306.
36. Critchley H.O.D., Kelly R.W., Kooy J. Perivascular expression of chemokine interleukin-8 in human endometrium. Hum. Reprod. 9:1994;1406-1409.
37. Milne S.A., Critchley H.O.D., Drudy T.A., Kelly R.W., Baird D.T. Perivascular interleukin-8 messenger ribonucleic acid expression in human endometrium varies across the menstrual cycle and in early pregnancy decidua. J. Clin. Endocrinol. Metab. 84:1999;2563-2567.
38. Colditz I.G. Effect of exogenous prostaglandin E2 and actinomycin D on plasma leakage induced by neutrophil activating peptide-1/interleukin-8. Immunol. Cell Biol. 68:1990;397-403.
39. Rampart M., Van Damme J., Zonnekyn L., Herman A.G. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am. J. Pathol. 135:1989;21-25.
40. Schatz F., Papp C., Aigner S., Krikun G., Hausknecht V., Lockwood C.J. Biological mechanisms underlying the clinical effects of RU486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression. J. Clin. Endocrinol. Metab. 82:1997;188-193.
41. Lockwood C.J., Krikun G., Hausknecht V.A., Papp C., Schatz F. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualisation and menstruation-related progestin withdrawal. Endocrinology. 139:1998;4607-4613.
42. Salamonsen L.A., Woolley D.E. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J. Reprod. Immunol. 44:1999;1-27.
43. Rudolph-Owen L.A., Slayden O., Matrisan L.M., Brenner R.M. Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients. Biol. Reprod. 59:1998;1349-1359.
44. Ylikorkala O., Makila U.M. Prostacyclin and thromboxane in gynecology and obstetrics. Am. J. Obstet. Gynecol. 152:1985;318-329.
45. Markee J.E. Menstruation in intraocular transplants in the rhesus monkey. Contrib. Embryol. Carnegie Inst. 177:1940;211-308.
46. Zhang J., Salamonsen L.A. Expression of hypoxia-inducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation. Hum. Reprod. 17:2002;265-274.
47. Sharkey A.M., Day K., McPherson A., Malik S., Licence D., Smith S.K.et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J. Clin. Endocrinol. Metab. 85:2000;402-409.
48. Nayak N.R., Brenner R.M. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J. Clin. Endocrinol. Metab. 87:2002;1845-1855.
49. Nayak N.R., Critchley H.O.D., Slayden O., Menrad A., Chwalisz K., Baird D.T.et al. Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J. Clin. Endocrinol. Metab. 85:2000;3442-3452.
50. Kelly R.W., King A.E., Critchley H.O.D. Cytokine control in human endometrium. Reproduction. 121:2001;3-19.
51. King A., Gardner L., Loke Y.W. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum. Reprod. 11:1996;1079-1082.
52. Henderson T.A., Saunders P.T., Moffet-King A., Groome N.P., Critchley H.O.D. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab. 88:2003;440-449.
53. Stewart J., Bulmer J.N., Murdoch A.P. Endometrial leucocytes: expression of steroid hormone receptors. J. Clin. Pathol. 51:1998;121-126.
54. Slayden O.D., Mah K., Brenner R.M. A critical period of progesterone withdrawal exists for endometrial MMPs and menstruation in macaques. Program. Society for the Study of Reproduction. Abstract 579. Biol. Reprod. 60(Suppl. 1):1999;273.
55. Baulieu E.E. Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science. 245:1989;1351-1357.
56. Baulieu E.E. The antisteroid RU486. Its cellular and molecular mode of action. Trends Endocrinol. Metab. 2:1991;233-239.
57. Critchley H.O.D., Kelly R.W., Lea R.G., Drudy T.A., Jones R.L., Baird D.T. Sex steroid regulation of leukocyte traffic in human decidua. Hum. Reprod. 11:1996;2257-2262.
58. Wang J.D., Fu Y., Zhu J.B. Lymphocyte population in human decidua after RU486 treatment. Biol. Reprod. 52(Suppl. 11):1995;184.
59. Cheng L., Kelly R.W., Thong K.J., Hume R., Baird D.T. The effects of mifepristone (RU486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy. Hum. Reprod. 8:1993;705-709.
60. Cameron S.T., Critchley H.O.D., Thong K.J., Buckley C.H., Williams A.R., Baird D.T. Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum. Reprod. 11:1996;2518-2526.
61. Berthois Y., Brux J.D., Salat-Baroux J., Kopp F., Cornet D., Martin P.M. A multiparametric analysis of endometrial estrogen and progesterone receptors after the postovulatory administration of mifepristone. Fertil. Steril. 55:1991;547-554.
62. Cameron S.T., Critchley H.O.D., Buckley C.H., Kelly R.W., Baird D.T. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation. Fertil. Steril. 67:1997;1046-1053.
63. Gemzell-Danielsson K., Wetlund P., Johannisson E., Swahn M.L., Bygdeman M., Seppala M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum. Reprod. 11:1996;256-264.
64. Gemzell-Danielsson K., Swahn M.L., Wetlund P., Johannisson E., Seppala M., Bygdeman M. Effects of daily low doses of mifepristone on ovarian function and endometrial development. Hum. Reprod. 12:1997;124-131.
65. Johannisson E., Oberholzer M., Swahn M.-L., Bygdeman M. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception. 39:1988;103-117.
66. Baird D.T., Cameron S.T., Critchley H.O.D., Drudy T.A., Howe A., Jones R.L.et al. Prostaglandins and menstruation. Eur. J. Obstet. Gynecol. Reprod. Biol. 70:1996;15-17.
67. Hapangama D.K., Critchley H.O.D., Henderson T.A., Baird D.T. Mifepristone-induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase 2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium. J Clin Endocrinol Metab. 87:2002;5229-5234.
68. Brown A., Cheng L., Lin S., Baird D.T. Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomised control trial of 2 and 5 mg per day for 120 days. J. Clin. Endocrinol. Metab. 87:2002;63-70.
69. Wolf J.P., Hsiu J.G., Anderson T.L., Ulmann A., Baulieu E.E., Hodgen G.D. Noncompetitive antiestrogenic effect of RU486 in blocking estrogen-stimulated luteinising hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil. Steril. 52:1989;1055-1060.
70. Brenner R.M., Slayden O.D., Critchley H.O.D. Antiproliferative effects of progesterone antagonists in the primate endometrium: a potential role for the androgen receptor. Reproduction. 124:2002;167-172.